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Background
Efforts have been made to develop new methods to
improve the diagnosis of intraductal lesions and their sur-
gical removal. We evaluated the therapeutic value of a new
scarless operation, endoscopic papillomectomy, (EP) in
patients with pathologic nipple discharge (PND).
Methods
Breast ductoscopy was performed on 213 female patients
with PND. These patients underwent a variety of appro-
priate ductoscopy-assisted (DA) endosurgical interven-
tions, combined with cytologic examinations. Success was
determined by recurrence of PND and by standard radio-
logical examinations.
Results
Ductoscopy was successfully performed in 178 patients.
Of these 178 patients, 34 had solitary papillomas (SP), 8
had multiple papillomas (MP), 19 had intraductal debris
and 5 had ductal epithelial surface abnormality with pos-
itive cytology. Of the 34 polypoid lesions (cytology nega-
tive), 22 were excised endoscopically (endoscopic
papillomectomy). Patients with MP underwent DA-
microdochectomy. These 42 patients (34 with SP, and 8
with MP) had histopathology results consistent with
intraductal papillomas or papillomatosis. Five patients
with positive cytology underwent DA-terminal ductal lob-
ular unit excision after their histopathology reports
showed had DCIS. Except in one patient, all discharges
disappeared. After a mean ± SD follow up time of 14.4 ±
5.2 months (range, 1–27 months), there were no recur-
rences of nipple discharge and no radiological results sug-
gestive of malignancy. Thus, the therapeutic efficacy of EP
in our study was 95.4% (21/22).
Conclusion
Ductoscopy is not only a diagnostic procedure, but is also
therapeutic for breast papillomas. EP is a new scarless
treatment option for patients with PND (1,2). With tech-
nical improvements in ductoscopy and endoscopic sam-
pling instruments, a greater degree of therapeutic efficacy
will be achieved.
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